UNSPSC 51111832: Aminoglutethimide

This classification denotes a non-steroidal aromatase inhibitor and anti-adrenal with the molecular formula C13H16N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0O54ZQ14I9, chemically known as 2,6-piperidinedione, 3-(4-aminophenyl)-3-ethyl- but generally known as aminoglutethimide, which bears US NIH Compound Identifier 2145. Aminoglutethimide most often comes in base, phosphate, and racemic forms.

UNSPSC 51111832 Aminoglutethimide is a Commodity code that covers the procurement of aminoglutethimide, a pharmaceutical compound historically used in endocrine therapy and adrenal suppression. State and local health departments, correctional systems, and institutional healthcare providers purchase this medication to support patient treatment protocols where clinically indicated. The pharmaceutical is typically acquired through competitive bidding or cooperative purchasing agreements negotiated at the state or regional level, often as part of broader drug formulary contracts. Issuing bodies include state departments of health, county public health systems, state prison and correctional healthcare programs, and large municipal hospital networks that maintain institutional pharmacies.

The source provided contains no recent state or local contract opportunities posted under this code. Without posted solicitations, geographic concentration and representative recent activity cannot be characterized from available data.